InsidersTradesSigma
Track the Interpace Biosciences, INC. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, Interpace Biosciences, INC. has logged 9 reports. Market capitalisation: €46.3m. The latest transaction was filed on 20 August 2026 (Levée d'options). Among the most active insiders: McCarthy Christopher. The full history is accessible without an account.
9
Insider Decl.
n/a
Thresholds
€77,070
1 ops.
Buy Volume
n/a
n/a
Sell Volume
34Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 287 of 29,062 companies
87.3
score / 100
Value84
Quality91
FCF yld13%
Earn yld59%
EV/EBITDA9.1x
ROE226%
Gross mgn62%
Net mgn63%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 20 August 2026
Declarations9 total
1,966,763 shares0Common StockSEC:0001493152-26-039528:0
581,718 shares@ US$1.61Common StockSEC:0001493152-26-039528:1
277,009 shares0Common StockSEC:0001493152-26-039495:0
9,405,941 shares@ US$2.02100.0% of flowCommon StockSEC:0001493152-26-007093:0
13,861,386 shares@ US$2.02100.0% of flowCommon StockSEC:0001493152-26-005161:0
7,556 shares0Common StockSEC:0001641172-25-006211:0
10,000 shares0Common StockSEC:0001493152-24-005018:0
25,000 shares0Common StockSEC:0001493152-23-026319:0
10,855 shares@ US$8.68100.0% of flowCommon StockSEC:0001493152-21-012889:0
Canonical exit: 19 Aug 2021 (T+90)
9 of 9 declarations
Acerca de Interpace Biosciences, INC.
Interpace Biosciences, INC. es una empresa centrada en el desarrollo de pruebas de diagnóstico y soluciones biotecnológicas para el sector sanitario. Su objetivo es mejorar los resultados clínicos mediante análisis genéticos y moleculares.
